Free Trial

Analysts Offer Predictions for Henry Schein Q1 Earnings

Henry Schein logo with Medical background

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Research analysts at Barrington Research decreased their Q1 2025 earnings per share estimates for Henry Schein in a note issued to investors on Wednesday, February 26th. Barrington Research analyst M. Petusky now expects that the company will earn $1.04 per share for the quarter, down from their previous estimate of $1.06. Barrington Research has a "Outperform" rating and a $90.00 price objective on the stock. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein's Q2 2025 earnings at $1.16 EPS, Q4 2025 earnings at $1.34 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.28 EPS, Q3 2026 earnings at $1.37 EPS, Q4 2026 earnings at $1.43 EPS, FY2026 earnings at $5.22 EPS and FY2027 earnings at $5.65 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.66 EPS.

Several other equities analysts also recently weighed in on HSIC. Mizuho assumed coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price for the company. Wells Fargo & Company assumed coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target on the stock. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday. Finally, Jefferies Financial Group upped their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.

Check Out Our Latest Stock Report on HSIC

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $0.05 during midday trading on Thursday, hitting $72.17. 11,190,666 shares of the stock were exchanged, compared to its average volume of 1,992,676. Henry Schein has a twelve month low of $63.67 and a twelve month high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a 50 day moving average price of $74.39 and a 200-day moving average price of $72.45. The stock has a market cap of $9.00 billion, a P/E ratio of 29.70, a PEG ratio of 2.13 and a beta of 0.91.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors have recently modified their holdings of the company. Menard Financial Group LLC acquired a new position in shares of Henry Schein in the fourth quarter valued at approximately $92,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Henry Schein in the fourth quarter valued at approximately $5,743,000. Jefferies Financial Group Inc. raised its position in shares of Henry Schein by 98.8% in the fourth quarter. Jefferies Financial Group Inc. now owns 83,100 shares of the company's stock valued at $5,751,000 after buying an additional 41,300 shares during the last quarter. Mackenzie Financial Corp increased its position in Henry Schein by 97.2% during the fourth quarter. Mackenzie Financial Corp now owns 8,819 shares of the company's stock worth $610,000 after purchasing an additional 4,348 shares during the last quarter. Finally, Forum Financial Management LP acquired a new position in Henry Schein during the fourth quarter worth approximately $221,000. Institutional investors and hedge funds own 96.62% of the company's stock.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla Sinks on Musk Drama—Bounce or Bigger Crash?
3 AI Stocks to Watch After NVIDIA’s Dip
Congress Cashes In on Stocks—Here’s How You Can Too!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines